Home
Daniel Karlin, Chief Medical Officer: Definium Therapeutics DFTX Sell · Filed 03/26
Trade details
- Type
- Insider sale
- Amount
- $148,092.46
- Shares · price
- 8,018 sh · $18.47 a share
- Held after
- 413,317 sh
- Trade date
- 26/03/25
- Filed
- 26/03/26
- Days to filing
- 1 days
Sold 1.9% of holdings
- Share of holding sold
- 1.9%
Definium Therapeutics trades, last 26 weeks
What else happened in Definium Therapeutics around then
Filed or reported within 30 days of the trade day · 02/23~04/24Daniel Karlin's recent trades
- Daniel Karlin
Sell10b5-1 planDefinium Therapeutics
Sell10b5-1 planDefinium Therapeutics
DFTX
$396.9K
10,853 sh
$396.9K
Filed 09/29
Traded 09/25
- Daniel Karlin
Planned saleDefinium Therapeutics
Planned saleDefinium Therapeutics
DFTX
$398.6K
10,853 sh
$398.6K
Filed 09/25
Traded 09/25
- Daniel Karlin
Sell10b5-1 planDefinium Therapeutics
Sell10b5-1 planDefinium Therapeutics
DFTX
$451.9K
10,035 sh
$451.9K
Filed 06/26
Traded 06/25
- Daniel Karlin
Planned saleDefinium Therapeutics
Planned saleDefinium Therapeutics
DFTX
$422.8K
10,035 sh
$422.8K
Filed 06/25
Traded 06/25
- Daniel Karlin
Planned saleDefinium Therapeutics
Planned saleDefinium Therapeutics
DFTX
$148.1K
8,018 sh
$148.1K
Filed 03/25
Traded 03/25